1/4 Effect of aspirin on cancer incidence and mortality in older adults academic.oup.com/jnci/advance-a… Our new results show aspirin's effects may differ in older adults, underscoring need for precision prevention.Ray DuBois, MD, PhD AsCaP - Aspirin for Cancer Prevention International Aspirin Foundation MassGeneral News Sir John Burn @NCIprevention

We’re excited to launch our Early Detection and Diagnosis of Cancer Roadmap which aims to unite fragmented efforts across the UK to drive progress in the early detection and diagnosis of cancer. Now is the time for action – bit.ly/3cUkhlx #EDDRoadmap #EarlyDetection

On the Cover of Cancer Prevention Research! Congrats to the Clinical & Translational Epidemiology Unit - MGH MGH Division of Gastroenterology investigator team for delivering on this Precision @NCIprevention aspirin RCT! Mass General Cancer Center @MGH_RI SU2Cscience International Aspirin Foundation AsCaP - Aspirin for Cancer Prevention The Aspirin Project Eduardo Vilar Sir John Burn

👏🏽Congrats to true giants in the field of aspirin and chronic disease prevention🥂 AsCaP - Aspirin for Cancer Prevention Sir John Burn The Aspirin Project

Please check out AsCaP PhD student Brinda speaking at Cancer Research UK Coaching the Rising Stars of Cancer Research (22.18) youtube.com/watch?v=F24jtL…

🗞️Beyond screening! #ColorectalCancer is preventable. My Harvard Health blog on Marc Bardou review in Gut Journal Mass General Cancer Center Stand Up To Cancer Damon Runyon Cancer Research Foundation Fight Colorectal Cancer AsCaP - Aspirin for Cancer Prevention International Aspirin Foundation 👇🏽 Can I take something to prevent colorectal cancer? - go.shr.lc/2K9TiZk via Shareaholic

Happy #InternationalWomensDay! To mark #IWD2021, we asked some of our staff and students to tell us about their female role models. Hear from Brinda, Nadia, Elly, Giulia and Maria about who inspires them Barts and The London, Queen Mary Queen Mary University of London

Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO cohort - PubMed ⁦AsCaP - Aspirin for Cancer Prevention⁩ #chemoprevention pubmed.ncbi.nlm.nih.gov/33974712/

Aspirin may help treat aggressive breast cancer bbc.in/3ANOU76

MY REVIEW IS OFFICIALLY PUBLISHED! 🥳🎉sciencedirect.com/science/articl… The topic? Aspirin is increasingly being used for cancer prevention, but we don't know if and how people use it. So we undertook a systematic review. What did we find? (continued below) AsCaP - Aspirin for Cancer Prevention Sam Smith

2022 marks 125 years since Felix Hoffmann developed and patented a process for synthesising acetyl salicylic acid or #aspirin. It has since been found to have many valuable uses, including in the prevention and management of #cancer aspirin-foundation.com/aspirin-summar… #125yearsofaspirin

New preprint of my 2nd PhD study - a qualitative study exploring the barriers and facilitators to the use of aspirin for CRC prevention among people with Lynch syndrome and healthcare providers. Read it here 👇 psyarxiv.com/swvf9/

🌟NEW PUBLICATION 🌟 My 2nd PhD study is officially published. We explored the barriers and facilitators to aspirin for colorectal cancer prevention among people with #Lynchsyndrome and healthcare providers hccpjournal.biomedcentral.com/articles/10.11… See thread below for summary of findings 🧵

Barriers and facilitators to using #aspirin for preventive therapy: the views and experiences of people with #Lynchsyndrome and GPs pubmed.ncbi.nlm.nih.gov/35999639/

If you enjoyed our Introductory Lecture from Professor Carlo Patrono, you may be interested in further reflections on his incredible career on our Aspirin Matters podcast aspirin-foundation.com/aspirin-matter… #125yearsofaspirin #aspirin

Meeting of the AsCaP Group on 24 & 25 October in London.

EXCITING NEWS 🎉🥳 We have a new paper (a RegisteredReports) out today in the The British Journal of General Practice 👇 Study has also been published as a press release here: leeds.ac.uk/main-index/new… 🧵 study aims and findings below 👇

Tens of thousands more women at increased risk of breast cancer could benefit from a risk-reducing drug on the NHS, after it was licensed in a new use to help prevent the disease. That’s more women like Lesley who said it was 'life-changing'. ➡️ england.nhs.uk/2023/11/tens-o…

Drug that can halve breast cancer risk offered to 289,000 women in England theguardian.com/society/2023/n…

Peter Sasieni Many congratulations to Professor Cuzick and his team for this fantastic piece of work #Anastrozole #breastcancer